Nanoparticle Loaded Polymeric Microbubbles as Contrast Agents for Multimodal Imaging
Nutte Teraphongphom, Peter Chhour, John R. Eisenbrey, Pratap C. Naha, Walter R. T. Witschey, Borirak Opasanont, Lauren Jablonowski, David P. Cormode and Margaret A. Wheatley
Ultrasound contrast agents are typically microbubbles (MB) with a gas core that is stabilized by a shell made of lipids, proteins, or polymers. The high impedance mismatch between the gas core and an aqueous environment produces strong contrast in ultrasound (US). Poly(lactic acid) (PLA) MB, previously developed in our laboratory, have been shown to be highly echogenic both in vitro and in vivo. Combining US with other imaging modalities such as fluorescence, magnetic resonance imaging (MRI), or computerized tomography (CT) could improve the accuracy of many US applications and provide more comprehensive diagnostic information. Furthermore, our MB have the capacity to house a drug in the PLA shell and create drug-loaded nanoparticles in situ when passing through an ultrasound beam. To create multimodal contrast agents, we hypothesized that the polymer shell of our PLA MB platform could accommodate additional payloads. In this study, we therefore modified our current MB by encapsulating nanopartides including aqueous or organic quantum dots (QD), magnetic iron oxide nanopartides (MNP), or gold nanopartides (AuNP) to create bimodality platforms in a manner that minimally compromised the performance of each individual imaging technique.
Nanoparticle Loaded Polymeric Microbubbles as Contrast Agents for Multimodal Imaging
Creators
Nutte Teraphongphom - Drexel Univ, Sch Biomed Engn Sci & Hlth Syst, Philadelphia, PA 19104 USA
Peter Chhour - University of Pennsylvania
John R. Eisenbrey - Thomas Jefferson University
Pratap C. Naha - University of Pennsylvania
Walter R. T. Witschey - University of Pennsylvania
Borirak Opasanont - Drexel University
Lauren Jablonowski - Drexel University
David P. Cormode - University of Pennsylvania
Margaret A. Wheatley - Drexel University
Publication Details
Langmuir, v 31(43), pp 11858-11867
Publisher
American Chemical Society; Washington, DC
Number of pages
10
Grant note
University of Pennsylvania
R00EB012165 / NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING; United States Department of Health & Human Services; National Institutes of Health (NIH) - USA; NIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)
SIR Foundation Allied Scientist Grant
T32HL007954 / NATIONAL HEART, LUNG, AND BLOOD INSTITUTE; United States Department of Health & Human Services; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)
R00 EB012165; R00 HL108157 / NIH grants; United States Department of Health & Human Services; National Institutes of Health (NIH) - USA
Resource Type
Journal article
Language
English
Academic Unit
School of Biomedical Engineering, Science, and Health Systems; Chemical and Biological Engineering
Web of Science ID
WOS:000364354800014
Scopus ID
2-s2.0-84946433759
Other Identifier
991019168458304721
UN Sustainable Development Goals (SDGs)
This publication has contributed to the advancement of the following goals:
InCites Highlights
Data related to this publication, from InCites Benchmarking & Analytics tool: